Introduction
The RUNX1 transcription factor (TF) is encoded by one of the most frequently mutated genes in myeloid malignancies, including de novo and secondary Acute Myeloid Leukemia (AML), [1] [2] [3] [4] [5] Myelodysplasia (MDS), [6] [7] [8] [9] [10] [11] and Chronic Myelomonocytic Leukemia. 12, 13 RUNX1 mutations lead to the expression of no protein, a crippled protein, or a dominant-negative fusion protein (in the case of the (8;21) translocation.) Somatic alterations of the second RUNX1 allele, found at a high percentage in AMLs, 1, 5 suggest a classical tumor suppressor.
Runx1 has been implicated in mechanisms controlling apoptosis, cell-cycle control, ribosome biogenesis, and decisions involving self-renewal and differentiation. [14] [15] [16] [17] [18] Although the disruption of any one of these processes likely contributes to neoplastic transformation, its pivotal tumor-protective function is likely regulating myeloid differentiation. are true long-term hematopoietic stem cells with high regenerative and proliferation capacity (i.e. self-renewal), but the majority are multipotent progenitors (MPP) that lack extended selfrenewal capacity and demonstrate a continuum of restricted differentiation potential. [19] [20] [21] [22] Recent results suggest that Megakaryocyte (Meg) potential can be closely linked to selfrenewal capacity 23, 24 and an MPP subset with pronounced Meg but no lymphoid potential has been identified. 22, 25, 26 MPPs give rise to lineage-committed myeloid progenitors (MP), which have lost self-renewal capacity and multipotency, but whose numbers are expanded through proliferation.
The extra-and intracellular mechanisms that regulate lineage-restriction and selfrenewal capacity during this differentiation process remain poorly understood. Lineagespecific cis-regulatory elements that are gained or lost during commitment have been identified and TF complexes that bind these elements delineated. 27, 28 Runx1 co-localizes with TFs specific for the HSC/MPP compartment, 29 but is also implicated in TF complexes
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progenitors, 32 and cells of the lymphoid compartment. 33, 34 To decipher the function and importance of Runx1 within these TF complexes, the consequence of its inactivation has been studied in mouse models. An important finding is the observed 3-to 8-fold expansion of the LSK population in the absence of Runx1, 33,35-37 suggesting a key function in selfrenewal/differentiation decisions. The MP compartment is also expanded, whereas lymphoid progenitors are nearly absent in Runx1-deficient BM. This latter trait can be traced to crucial functions in initiating the B-cell program 33 and during early stages of T-cell development, 34 but a pivotal function of Runx1 in myeloid-cell fate has not been discerned. Indeed the sole, characterized myeloid defect in Runx1-deficient mice is impaired Meg maturation.
35,38
We reasoned that defects in cell fate decision in the early HSC/MPP compartment in Runx1-deficient mice should read-out in the downstream MP compartment, which has only been superficially examined in previous studies. This compartment may also be the target of leukemic transformation, as the transcriptome of the leukemic stem cell (LSC) can share high homology to GM progenitors (GMP).
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Methods
Mouse strains used for this study and the protocols used for fluorescence-activated cell sorting (FACS), gene expression analysis, and chromatin-immunoprecipitation have been reported previously 33 (detailed in the supplemental Methods and supplemental Tables S1   and S2 ).arr
Transplantation experiments
For rescue experiments BM cells were isolated from Runx1 Media (ThermoFisher Scientific) supplemented with SCF (50ng/ml), IL3 (10ng/ml), and Thpo (50ng/ml) for 6 days.
Results and Discussion
Phenotypically abnormal MP compartment in Runx1 deficient mice
In a first step to characterize the MP compartment of Runx1-deficient BM, we performed FACS analysis that permits separation of G/M and Meg/Ery bipotent progenitors (GMP; MEP), as well as Meg or Ery monopotent progenitors (MkP; EryP) 44 ( Figure 1A, B) . A 5-fold increase in absolute MP numbers was observed in Runx1 Δ /Δ as compared to Runx1 +/+ mice ( Figure 1C ). This number is higher than that observed in interferon-inducible Runx1-deficient models, 38, 45 in which excision was induced in newborns as opposed to fetal liver and may have been incomplete. A striking difference in the distribution of the various BM progenitors in knockout (KO) and wildtype (WT) mice was also found ( Figure 1D ,E). Although the relative proportion of EryP was similar in mice of both genotypes (with an overall 5-fold increase in KOs), relatively higher proportions of MEP and MkP were observed in the KOs (with a 10-fold increase for each population) and a 2-to 3-fold increase in actual numbers in GM progenitors. Several cell surface markers showed altered expression levels on Runx1-deficient progenitors; whereas the CD105/Endoglin marker on EryP was diminished, the CD150/Slamf1 marker on MEP was increased ( Figure 1B ), as previously reported for HSC/MPP.
36
Importantly, Runx1-deficient BM also contained an undefined myeloid progenitor (XMP) that was positive for both the MEP marker CD150 and the myeloid markers CD16/32 (FcγRII/III) ( Figure 1B,D) . Previous reports have used the CD34 myeloid marker to distinguish between MEP and GMP, and to define a common myeloid progenitor (CMP) 38 -now known to be composed of G/M and Meg/Ery bi-and monopotent progenitors. 44 Using this older FACS strategy, the XMP population appears as a CD34 lo "CMP" (supplementaöl Figure 1B) . However, staining with the MkP CD41 marker showed high positivity on XMP (supplemental Figure 1C) , supporting the hypothesis that XMP may be an aberrant Meg progenitor. Of note, high CD41 expression on an undefined MP cells has also been previously reported. Figure 3A ,B). Low Gr1-antigen levels on Runx1-deficient cells in vitro was also reported in a previous study, but this was attributed to a switch from granulopoiesis to monopoiesis. 47 Using specific antibodies for markers highly expresses on monocytes (Ly6c) and granulocytes (Ly6g), rather than the Gr1 antibody that recognizes both antigens, 48 our analysis demonstrated that the M to G ratio in BM and peripheral blood was unchanged in Runx1-deficient mice, but the expression levels of both Ly6c and Ly6g on granulocytic cells varied (supplemental Figure 3C -E).
Furthermore, blood values for monocytes and neutrophils were comparable to controls (supplemental Figure 3F) . Consistent with the observed immature morphology in colony Thirdly, our analysis confirmed an increased propensity towards megakaryocyte differentiation in Runx1-deficient progenitors. This was most striking in colony assays from early preGMP, but also observed using total progenitors (Lin -). Low levels of Ery and Meg differentiation have been reported for preGMP, 44 but we observed a large proportion of GEMM-like colonies that contained high levels of Meg precursors, in addition to G/M progenitors ( Figure 2B , and supplemental Figure 2A ,B). Using FACS analysis as an unbiased tool to quantitate the lineage affiliation of progeny cells, a 5-fold increase in CD41+ cells was confirmed ( Figure 2D ,F). We also confirmed that the unique XMP were Meg progenitors, as they gave rise to predominantly aberrant CFU-Meg colonies containing CD41+ cells ( Figure 2B ,G). Runx1-deficiency is known to impede Meg maturation and production of platelets, 35,38,49 which normally bind Thpo to control their own production. 50 Thus aberrantly high Thpo levels may lead to the increase in Meg progenitors in Runx1
mice. However, Thpo plasma levels were significantly reduced in Runx1-deficient mice ( Figure 2I ), likely due to the ability of Meg precursors to also "sink" Thpo. The impact on Ery differentiation was unexpected, as Runx1-deficient mice exhibit normal red blood cell parameters (supplemental Figure 3F ) and previous studies have reported normal numbers of BFU-E within Runx1-deficient BM progenitors based on clone morphology. 35, 38 We postulate that this latter discrepancy may reflect either mistaken scoring of the morphologically similar CFU-GEMM-like colonies as BFU-E (supplemental Figure 2B) or incomplete excision of the Runx1 gene. As compensation mechanisms may obscure ineffective erythropoiesis in vivo, we performed competitive transplantation experiments.
Analysis of BM and blood, showed the expected loss of donor-derived B-cells (supplemental conversely, the upregulated genes are normally expressed in either MkP or GMPs ( Figure   3D ,E). We next assessed the expression levels of 1745 genes encoding TF 54 and found eight genes significantly differentially expressed in XMPs, including high levels of Fli1 and low levels of Klf1 transcripts ( Figure 3F , supplemental Figure 4D) . No differential expression was observed in TFs that specify Meg or Ery differentiation (e.g. Gfib1, Fli1, Klf1, or Gata1); on the contrary, Runx1
MEPs showed significantly increased levels of Klf3, Lyl1 and Arrb1 (implicated in Ery maturation) 58, 59 and decreased levels of Gata2 (a known Meg factor) 55 ( Figure 3F and supplemental Figure 4B ,C). Thus we find it unlikely that the defective erythropoiesis in
Runx1
Δ /Δ mice reflects a skewed propensity toward Meg differentiation at the MEP level but rather a requirement for Runx1 in Ery development.
Deregulated Meg-primed lineage program identified in GMP and confirmed in LSK
To elucidate the mechanism underlying the increased GMP clonality but impaired G/M differentiation, differentially expressed TF genes in KO vs WT GMPs were determined. The genes encoding C/ebpα and Id2, TF involved in G/M maturation, 60, 61 were reduced by more than a factor of two ( Figure 4A and supplemental Figure 4E ,F). Lmo1 and Lmo4 were also significantly down-regulated in KO GMP, and although not previously implicated in G/M development, both genes are highly expressed in mature G (supplemental Figure 4E ).
These results are consistent with the observed immature phenotype in GMP colony assays and the importance of Runx1 in G/M differentiation, 18 a conclusion not reported in previous analyses of Runx1-deficient mouse models. Rescue experiment identifies direct Runx1-target genes whose products regulate
adhesion / motility
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To define direct target genes of Runx1 that conferred increased regenerative capacity and Meg cell fate decisions to GM progenitors, we performed rescue experiments ( Figure 5A ). For these experiments we used a RUNX1-ERt2 inducible system, whose ability to reverse the block to GM development was confirmed in colony assays (supplemental Figure 5A-D) . A total of 238 deregulated genes were identified whose expression pattern could be rescued (reversed) by RUNX1 reactivation ( Figure 5B and supplemental Table 3 ). Figure 5D ). Similar enriched signatures (cell adhesion, focal adhesion, signaling pathways) were also found by GSEA (supplemental Figure 6A) . We also reassessed the deregulated genes in AML patient samples with RUNX1 inactivating mutations. 66 Strikingly, GO analysis of 235 deregulated genes showed the same affected pathways found in Runx1-deficient GMPs (supplemental Figure 6B) . Shared deregulated genes included ITGB2, CD302, PLXNC1, JAM3, and PYHIN1. Notably, in vitro experiments confirmed increased binding of Runx1-deficient MPs to MS-5 stromal cells ( Figure 5E ).
Genes upregulated in Runx1
To identify key Runx1-target genes responsible for the observed Meg-skewing and self-renewal capacity, we determined which of our identified Runx1-target genes are expressed during the transition from HSC to the pro-Meg MPP2, but repressed in MPPs that loose Meg potential 26 (supplemental Figure 6C,D) . Several candidate genes were examined for their ability to increase Meg-differentiation capacity in sorted LSK cells. The angiopoietin receptor Tek consistently increased Meg output ( Figure 5F ). Several studies have demonstrated the importance of Tek in HSC function and interaction with the BM stroma.
67-69
These results suggest that although several parallel and divergent pathways mediate
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Identification of Runx1 binding sites in GMP-like cells and verification of target genes
To further confirm direct Runx1 target genes, we performed ChIP-seq analysis for Runx1 binding in FDC-P1 cells, which have an immunophenotype and differentiation capacity similar to GMPs (supplemental Figure 7A ). Runx1-transduced FDC-P1 revealed a larger number of Runx1-bound regions than endogenous Runx1 levels, but shared binding sites were identified ( Figure 6A ). Of these, 37% overlapped with Runx1-binding sites obtained with the "MPP-like" HPC7, which have maintained Meg/Ery differentiation potential.
29
Motif search analysis in the immediate vicinity of the Runx1 summit identified Runx1 consensus motifs in 100% of the assayed peaks ( Figure 6B ). This is in contrast to previous Figure 6C ). Circa 30% of the Runx1 peak summits in FDC-P1 cells were within 300bp of both C/ebpa and Gfi1 binding sites; indeed, more than half of the Runx1 peaks overlapped with Gfi1 peaks. In contrast, Scl1 peaks showed <18% overlap with Runx1 peaks in FDC-P1 cells but circa 50% with Runx1 peaks in HPC-7 cells. 29 We next mapped Runx1 binding sites to direct Runx1 target genes identified in the rescue experiment; 70% of the putative target genes were within 100 kb of a Runx1 binding 
